As of the program's launch, three medications are covered under the Medicare GLP-1 Bridge when prescribed specifically for weight management: Wegovy (semaglutide) both injectable pen and tablet forms Zepbound (tirzepatide) KwikPen injectable form Foundayo (oral semaglutide tablet) Important note: These medications are covered under this program only when prescribed for weight reduction and maintenance
Conversely, declining ghrelin concentrations reduce insulin sensitivity and impair pancreatic -cell function, diminishing insulin secretion and glucose regulation
However, since they are for research purposes only, ongoing studies are necessary to determine their full potential and long-term safety
Important considerations Check the specific drug product: It is essential to verify the exact product (e.g., capsule, injection) and the specific circumstances of administration to determine the correct code
A 0.3 ml syringe is ideal
How should Ozempic be administered